OBIO earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -2.56. Updated 2026-07-23.
Orchestra BioMed Holdings (OBIO) Research Hub
Orchestra BioMed Holdings (OBIO) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 6.12 USD (+12.29%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.56, market cap 0.22B. This hub links to the full technical, earnings and options research available for OBIO.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 6.12 USD (+12.29%) |
| 52-week range | 3.59 USD – 6.24 USD |
| Trend regime | Range |
| 14-day RSI | 76.9 (Overbought) |
| Trailing P/E | -2.56 |
| Market cap | 0.22B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for OBIO
Covered Call on OBIO: how it works, illustrative setup around the real 6.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OBIO: how it works, illustrative setup around the real 6.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OBIO: how it works, illustrative setup around the real 6.12 USD price, max profit/loss, breakeven and when to use it. Educational.
OBIO technical analysis: range, last 6.12 USD, RSI 76.9, 52w range 3.59 USD–6.24 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is OBIO in?
Orchestra BioMed Holdings (OBIO) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is OBIO in an uptrend or downtrend?
As of 2026-09-11, OBIO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OBIO's trailing P/E ratio?
OBIO's trailing P/E is -2.56, with a market cap of 0.22B. See the earnings research page for full valuation detail.
When does OBIO next report earnings?
OBIO is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -0.35 USD.